Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures

Becker, Richard C. MD1,11; Scheiman, James MD2,11; Dauerman, Harold L. MD3; Spencer, Frederick MD4; Rao, Sunil MD5; Sabatine, Marc MD6; Johnson, David A. MD7; Chan, Frances MD8; Abraham, Neena S. MD9; Quigley, Eamonn M.M. MD10 in collaboration with the American College of Cardiology the American College of Gastroenterology

American Journal of Gastroenterology: December 2009 - Volume 104 - Issue 12 - p 2903–2917
doi: 10.1038/ajg.2009.667
ACG/JACC WHITE PAPER
Buy

The periprocedural management of patients with atherosclerotic coronary heart disease, including those who have heart disease and those who are undergoing percutaneous coronary intervention and stent placement who might require temporary interruption of platelet-directed pharmacotherapy for the purpose of an elective endoscopic gastrointestinal procedure, is a common clinical scenario in daily practice. Herein, we summarize the available information that can be employed for making management decisions and provide general guidance for risk assessment.

This article has been copublished in the 8 December 2009 issue of the Journal of the American College of Cardiology.

© 2009 by the American College of Cardiology Foundation. Reprinted with permission from the American College of Cardiology Foundation.

1Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina, USA; 2University of Michigan, Ann Arbor, Michigan, USA; 3University of Vermont, Burlington, Vermont, USA; 4McMaster University, Hamilton, Ontario, Canada; 5Durham VA Medical Center, Durham, North Carolina, USA; 6Brigham and Women's Hospital, Boston, Massachusetts, USA; 7Eastern Virginia School of Medicine, Norfolk, Virginia, USA; 8Chinese University of Hong Kong, Hong Kong, China; 9Baylor College of Medicine, Houston, Texas, USA; 10National University of Ireland at Cork, Cork, Ireland. 11These authors contributed equally to this paper. For full author disclosures, please see the end of this article. Correspondence: Richard C. Becker, MD, Duke Clinical Research Institute, Cardiovascular Medicine, 2400 Pratt Street, Terrace Level, Room 0311, Durham, North Carolina 27705, USA. E-mail: becke021@mc.duke.edu

© The American College of Gastroenterology 2009. All Rights Reserved.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website